go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

sanofi-aventis
Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 4035600
Fax: +353 1 4035687
Medical Information e-mail: IEmedinfo@sanofi-aventis.com
Summary of Product Characteristics last updated on medicines.ie: 07/05/2010
SPC Maalox 225mg/200mg per 5ml Oral Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 07/05/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 1 - Name of medicinal product
Date of revision of text on the SPC:   01-Apr-2010
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company
Change to product name
Updated on 01/09/2009 and displayed until 07/05/2010
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 2 - Qualitative and quantitative composition
Date of revision of text on the SPC:   01-Aug-2009
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company
Correction of typing errors & update of excipient warning.
Updated on 08/10/2008 and displayed until 01/09/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 09/08/2007 and displayed until 08/10/2008
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Date of revision of text on the SPC:   05/2007
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company
Update section 4.4 - warnings
section 4.5 - interactions
Updated on 07/11/2006 and displayed until 09/08/2007
Reasons for adding or updating:
  • Change to section 7 - Marketing authorisation holder
Date of revision of text on the SPC:   09/2006
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company
Update
Section 7 - Marketing Authorisation Holder changed to sanofi-aventis Ireland Ltd.
Updated on 04/09/2006 and displayed until 07/11/2006
Reasons for adding or updating:
  • Change to section 6.4 - Special precautions for storage
Date of revision of text on the SPC:   05/2006
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company
Update Section 6.4 - Deletion of 'once opened use within 28 days'.
Updated on 27/07/2006 and displayed until 04/09/2006
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 25/04/2006 and displayed until 27/07/2006
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 17/05/2005 and displayed until 25/04/2006
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 16/02/2005 and displayed until 17/05/2005
Reasons for adding or updating:
  • Change to section 1 - Name of medicinal product
  • Change to section 6.1 - List of excipients
  • Change to section 10 - Date of revision of the text
Updated on 15/02/2005 and displayed until 16/02/2005
Reasons for adding or updating:
  • Change to section 6.5 - Nature and contents of container
Updated on 08/01/2004 and displayed until 15/02/2005
Reasons for adding or updating:
  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - MA number
  • Change to section 10 - Date of revision of the text
Updated on 16/06/2003 and displayed until 08/01/2004
Reasons for adding or updating:
  • New SPC for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Aluminium Hydroxide
  Magnesium Hydroxide